🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523304-68-00
Completed Phase I

A research study to evaluate the safety of NNC1679-0001 when given to healthy participants and participants with T2DM

2025-523304-68-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
19/04/2026
Enrollment target
58
Sites
Austria

Condition studied

Healthy participants and participants with type 2 diabetes

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523304-68-00 on CTIS ↗ ← All trials in the EU